Cabozantinib (CABO) plus durvalumab (DURVA) in patients (pts) with advanced urothelial carcinoma (UC) after platinum chemotherapy: Safety and preliminary activity of the open-label, single-arm, phase II ARCADIA trial

被引：2
|
作者：
Marandino, L. [1 ]
Raggi, D. [1 ]
Giannatempo, P. [1 ]
Calareso, G. [2 ]
Alessi, A. [3 ]
Colecchia, M. [4 ]
Madison, R. [5 ]
Ross, J. S. [6 ]
Necchi, A. [1 ]
机构：
[1] Ist Nazl Tumori Milano Fdn IRCCS, Dept Med Oncol, Milan, Italy
[2] Ist Nazl Tumori Milano, Fdn IRCCS, Radiol, Milan, Italy
[3] Ist Nazl Tumori Milano Fdn IRCCS, Nucl Med, Milan, Italy
[4] Ist Nazl Tumori Milano Fdn IRCCS, Pathol, Milan, Italy
[5] Fdn Med Inc, Clin Bioinformat Operat, Cambridge, MA USA
[6] Fdn Med Inc, Cambridge, MA USA
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.annonc.2020.08.845
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
773P
引用
收藏
页码：S595 / S595
页数：1
相关论文
共 50 条
  • [31] Phase II Open-Label, Single-Arm Trial to Investigate the Efficacy and Safety of Topical Remetinostat Gel in Patients with Basal Cell Carcinoma
    Kilgour, James M.
    Shah, Aatman
    Urman, Nicole M.
    Eichstadt, Shaundra
    Do, Hanh N.
    Bailey, Irene
    Mirza, Amar
    Li, Shufeng
    Oro, Anthony E.
    Aasi, Sumaira Z.
    Sarin, Kavita Y.
    CLINICAL CANCER RESEARCH, 2021, 27 (17) : 4717 - 4725
  • [32] Neoadjuvant camrelizumab plus chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: A single-arm, phase II trial
    Gao, Jin
    Qian, Liting
    Zhou, Lingran
    Sun, Bin
    He, Jian
    Wang, Ru
    Zhang, Yangyang
    Yang, Liping
    Zhou, Yan
    Yang, Jing
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [33] Camrelizumab Plus Apatinib in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma: An Open-Label, Single-Arm, Phase II Study
    Ding, Xi
    Zhang, Wei-Jing
    You, Rui
    Zou, Xiong
    Wang, Zhi-Qiang
    Ouyang, Yan-Feng
    Peng, Lan
    Liu, You-Ping
    Duan, Chong-Yang
    Yang, Qi
    Lin, Chao
    Xie, Yu-Long
    Chen, Si-Yuan
    Liu, Yong-Long
    Gu, Chen-Mei
    Xie, Ruo-Qi
    Huang, Pei-Yu
    Hong, Ming-Huang
    Hua, Yi-Jun
    Chen, Ming-Yuan
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (14) : 2571 - +
  • [34] OVARIO: A single-arm, open-label phase II study of maintenance therapy with niraparib plus bevacizumab (bev) in patients (pts) with advanced ovarian cancer (OC) after response to frontline platinum-based chemotherapy (chemo)
    Hardesty, M.
    Hope, J. M.
    Krivak, T.
    Chen, J.
    Wainszelbaum, M.
    Gupta, D.
    Richardson, D.
    ANNALS OF ONCOLOGY, 2018, 29
  • [35] Anlotinib plus pemetrexed in patients with platinum-resistant ovarian cancer: A single-arm, open-label, phase II study
    Chen, J.
    Wei, W.
    Zheng, L.
    Li, H.
    Feng, Y.
    Wan, T.
    Huang, Q.
    Liu, G.
    Tu, H.
    Qiu, J.
    Jiang, X.
    Xiong, Y.
    Zheng, M.
    Li, J.
    Huang, H.
    Song, L.
    Liu, J.
    Zhang, Y.
    ANNALS OF ONCOLOGY, 2021, 32 : S734 - S734
  • [36] Effect of apatinib plus neoadjuvant chemotherapy followed by resection on pathologic response in patients with locally advanced gastric adenocarcinoma: A single-arm, open-label, phase II trial
    Zheng, Yanan
    Yang, Xiao
    Yan, Chao
    Feng, Runhua
    Sah, Birendra Kumar
    Yang, Zhongyin
    Zhu, Zhenglun
    Liu, Wentao
    Xu, Wei
    Ni, Zhentian
    Beeharry, Maneesh Kumarsing
    Hua, Zichen
    Yan, Min
    Zhu, Zhenggang
    Li, Chen
    EUROPEAN JOURNAL OF CANCER, 2020, 130 : 12 - 19
  • [37] Toripalimab plus intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma: an open-label single-arm, phase II trial
    Hua, Yijun
    You, Rui
    Wang, Zhiqiang
    Huang, Peiyu
    Lin, Mei
    Ouyang, Yanfeng
    Xie, Yulong
    Zou, Xiong
    Liu, Youping
    Duan, Chongyang
    Liu, Yonglong
    Gu, Chenmei
    Liu, Rongzeng
    Yang, Qi
    Jiang, Rou
    Zhang, Mengxia
    Ding, Xi
    Chen, Siyuan
    Lin, Chao
    Sun, Rui
    Chen, Mingyuan
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (11)
  • [38] Anlotinib plus sintilimab in patients with recurrent advanced endometrial cancer: A prospective open-label, single-arm, phase II clinical trial.
    Wei, Wei
    Ban, Xiaohua
    Yang, Fan
    Huang, Yongwen
    Li, Jibin
    Qiu, Ya
    Cheng, Xiaqin
    Li, Jundong
    Zheng, Min
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [39] Anlotinib in Chinese Patients With Recurrent Advanced Cervical Cancer: A Prospective Single-Arm, Open-Label Phase II Trial
    Zhu, Jun
    Song, Chunyan
    Zheng, Zhong
    Xia, Lingfang
    Chen, Yanqiong
    Ke, Guihao
    Wu, Xiaohua
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [40] Radiotherapy plus camrelizumab and irinotecan for oligometastatic esophageal squamous cell carcinoma patients after first-line immunotherapy plus chemotherapy failure: An open-label, single-arm, phase II trial
    Zhao, Wensi
    Ke, Shaobo
    Cai, Xiaojun
    Zuo, Zhigang
    Shi, Wei
    Qiu, Hu
    Cai, Gaoke
    Gong, Yi
    Wu, Yong
    Ruan, Shasha
    Chen, Yongshun
    RADIOTHERAPY AND ONCOLOGY, 2023, 184
12345